The system is designed for minimally invasive knee surgery and will be available for use in primary and revision knee surgeries. The company uses a lean business model that does not carry accumulated overhead and legacy costs, which lowers the cost of the technology.
Read the OrthoPathways release on the Stamina Knee.
Read other coverage on orthopedic and spine devices:
– Biomet Receives FDA 510(k) Clearance for Signature Personalized Total Knee Replacement System
– MedShape Solutions Announces Clinical Use of ExoShape CL During ACL Reconstruction
– InteliFUSE and Biomedical Enterprise Patent Dispute Over Orthopedic Device Settled
